{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:46:42Z","timestamp":1749574002116},"reference-count":33,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"vor","delay-in-days":5878,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[1997,5]]},"abstract":"<jats:p>Oral lesions cause considerable morbidity in association with HIV infection. Their successful management depends upon accurate diagnosis and the use of appropriate therapy. Various treatment approaches are described for some of the common oral lesions including Kaposi's sarcoma, oral candidiasis, hairy leukoplakia and recurrent oral ulcers associated with HIV disease. This paper will discuss the therapies available in the USA and UK. In other countries some of the drugs discussed will be available in different doses and preparations. In addition other drugs may be available in other parts of the world that are not licensed for use in the USA or UK, and their availability may vary.<\/jats:p>","DOI":"10.1111\/j.1601-0825.1997.tb00366.x","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T11:13:24Z","timestamp":1370344404000},"source":"Crossref","is-referenced-by-count":9,"title":["Management of the oral mucosal lesions seen in association with HIV infection"],"prefix":"10.1111","volume":"3","author":[{"given":"D","family":"Greenspan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ","family":"Shirlaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"The Medical Letter(1995).Drugs for AIDS and associated infections.The Medical Letter87\u201394."},{"key":"e_1_2_1_3_1","first-page":"362","volume-title":"Oral manifestations of HIV infection: Proceedings of the 2nd International Workshop on the Oral Manifestations of HIV Infection.","author":"Barr C","year":"1995"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70256-H"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300407"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92330-I"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1993.tb01074.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91114-8"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(94)90195-3"},{"key":"e_1_2_1_10_1","unstructured":"GraybillJR VasquezJ.DarouicheROet al(1995).Itraconazole oral solution versus fluconazole treatment of oropharyngeal candidiasis. Abstract 1220. 35th 1CAAC San Francisco CA."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1991.0242"},{"key":"e_1_2_1_12_1","volume-title":"AIDS and the mouth.","author":"Greenspan D","year":"1990"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90185-S"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512193132502"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.Supplement_3.S334"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199603000-00004"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02005444"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199401000-00011"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90097-A"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90093-J"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90122-7"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199608150-00005"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.1.219"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(93)92707-4"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4809172"},{"key":"e_1_2_1_26_1","first-page":"2276","article-title":"Thalidomide for severe aphthous ulceration in patients with human immunodeficiency virus (HIV) infection","volume":"89","author":"Oldfield ECR","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1993.tb00376.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.2.250"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(91)90524-G"},{"key":"e_1_2_1_30_1","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV\u2010infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group","volume":"6","author":"Pons V","year":"1993","journal-title":"J Acquir Immune Defic Synclr"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1989.tb01552.x"},{"key":"e_1_2_1_32_1","first-page":"463","article-title":"Azole drug resistance in Candida specie","volume":"31","author":"Warnock DW","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199209000-00022"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408303110904"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.1997.tb00366.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.1997.tb00366.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:20:36Z","timestamp":1698474036000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.1997.tb00366.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":33,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["10.1111\/j.1601-0825.1997.tb00366.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.1997.tb00366.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}